Concepedia

Publication | Open Access

Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes

DOIFull Paper Access

21

Citations

32

References

2021

Year

Yaqin Zhang, Ruofei Chen, Yangyang Jia, Mingwei Chen, Zongwen Shuai
Drug Design Development and Therapy

Abstract

The GLP-1R agonist exenatide can inhibit the activation state of platelets in patients with T2DM and inhibit thrombosis, which is beneficial to reduce the risk of cardiovascular events.

References

YearCitations

Page 1